
Eli Lilly’s huge 50-hectare manufacturing hub in Kinsale has placed Ireland at the centre of the biggest shift in global medicine in decades
Eli Lilly has paused its obesity awareness campaign in India after regulators warned it may violate drug advertising rules, raising compliance concerns.
By Rishika Sadam HYDERABAD, May 12 (Reuters) - Eli Lilly paused its obesity awareness campaign in India after the nation's drugs regulator warned the company it could violate rules against advertising prescription medicines to consumers even indirectly...